Galera Therapeutics is focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer.

For more information, visit Galera Therapeutics or follow their updates on:

Galera Therapeutics Articles

Galera Therapeutics Raises $150 Million to Advance “Breakthrough Therapy” for Debilitating Cancer Side Effect

EQ Staff, Jonathan Allen
3 Min Read

12 Fundraising Tips for BioTech Companies from Cultivation Capital’s Life Sciences Fund

EQ Staff, Jonathan Allen
4 Min Read

Cultivation Capital’s Life Sciences Fund Finds Sweet Spot

EQ Staff, Jonathan Allen
3 Min Read

Veniti’s CFO Catherine Matthes on Clinical Trial Funding

EQ Staff, Jonathan Allen
4 Min Read

Robert Beardsley on Galera Therapeutics’ High Growth

EQ Staff, Jonathan Allen
3 Min Read